GDF
PFE icon

Graham & Dodd Fund’s Pfizer PFE Stock Holding History

Graham & Dodd Fund’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$917K Sell
31,553
-24,095
-43% -$701K 2.79% 9
2013
Q3 		$1.52M Sell
55,648
-306
-0.5% -$8.33K 2.93% 5
2013
Q2 		$1.49M Buy
+55,954
New +$1.55M 2.96% 4

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Graham & Dodd Fund's PFE Position: Q4 2013 in Review

Graham & Dodd Fund reduced its Pfizer (PFE) stake by 43% in Q4 2013, selling an estimated $701K and leaving 31,553 shares worth $917K. The position accounts for 2.79% of the portfolio, ranked #9.

Graham & Dodd Fund first reported a position in PFE in Q2 2013 and has held it in 3 quarters since. The position peaked at $1.52M in Q3 2013. 1,737 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

  • Graham & Dodd Fund held 31,553 shares of Pfizer worth $917K as of Q4 2013.
  • Graham & Dodd Fund sold 24,095 Pfizer shares in Q4 2013, an estimated $701K.
  • Pfizer made up 2.79% of Graham & Dodd Fund's portfolio in Q4 2013, its #9 holding.
  • Graham & Dodd Fund first reported a position in Pfizer in Q2 2013 and has held it in 3 quarters since.
  • Graham & Dodd Fund's Pfizer position peaked at $1.52M in Q3 2013.
  • 1,737 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on Graham & Dodd Fund's 13F filing for Q4 2013, filed 11 Feb 2014.